Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Income from Continuing Operations (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of Income from Continuing Operations data on record, last reported at 53200000.0 in Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 593.34% year-over-year to 53200000.0; the TTM value through Dec 2025 reached 46532000.0, up 5304.41%, while the annual FY2025 figure was 46532000.0, 5304.41% up from the prior year.
  • Income from Continuing Operations reached 53200000.0 in Q4 2025 per ORGO's latest filing, up from 21567000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 53200000.0 in Q4 2025 and bottomed at 18843000.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 6605450.0, with a median of 6401000.0 recorded in 2022.
  • Peak YoY movement for Income from Continuing Operations: surged 1373.02% in 2023, then plummeted 797.29% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 19019000.0 in 2021, then crashed by 60.64% to 7486000.0 in 2022, then crashed by 80.71% to 1444000.0 in 2023, then skyrocketed by 431.37% to 7673000.0 in 2024, then surged by 593.34% to 53200000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 53200000.0 in Q4 2025, 21567000.0 in Q3 2025, and 9392000.0 in Q2 2025.